European Inhaler Market 2019 Growth, COVID Impact, Trends Analysis Report 2025
European inhaler market was valued at around $6.4 billion in 2018 and is anticipated to grow at a substantial rate of 2.3% during the forecast period. Major countries that will contribute to the inhaler market within the region includes UK, Germany, France, Italy and Spain. A significant number of companies, research, patient base has been observed in the market due to which a significant growth can be observed in the market. According to the International Monetary Fund (IMF), Europe is home to around 740 million people and the GDP of the European Union is $19.7 trillion in 2017. As per Organization for Economic Co-operation and Development (OECD), the self-reported asthma rate and COPD rate by European Union countries were 6.1% and 4.0% respectively and it has been found out that the rate of prevalence of diseases are higher in women as compared to men. This is expected to drive the regional business growth of the inhaler market.
To Request a Sample of our Report on European
Inhaler Market: https://www.omrglobal.com/request-sample/european-inhaler-market
The European inhaler market is segmented on the basis of
device, type, application, and end-user. On the basis of device, the market is
sub-segmented into metered dosed inhaler, dry powdered inhaler, and nebulizer.
The dry powder inhaler is estimated to have largest market share in the
European inhaler market due to providing easy inhalation solution. Whereas, the
market for metered dose inhaler is estimated to be the fastest growing at a
CAGR during the forecast period owing to innovations and collaborations by the
companies for the development of metered dosed inhaler. Based on the type, preventive,
reliever, and long acting bronchodilators inhaler are analyzed. Moreover, on
the basis of application, the market has been classified into asthma and COPD
diseases. In addition, based on the end-user, homecare and hospitals and
clinics have been analyzed.
(Get 15% Discount on Buying this Report)
A
full Report of European Inhaler Market is Available @ https://www.omrglobal.com/industry-reports/european-inhaler-market
European Inhaler Market Segmentation
By Device
·
Metered Dose Inhaler
·
Dry Powder Inhaler
·
Nebulizer
By Type
·
Preventive Inhaler
·
Reliever Inhaler
·
Long Acting Bronchodilators Inhaler
By Application
·
Asthma
·
Chronic Obstructive Pulmonary Disease (COPD)
By End-User
·
Homecare
·
Hospitals and Clinics
Regional Analysis
·
UK
·
Germany
·
France
·
Italy
·
Spain
Rest of Europe
Company Profiles
·
3M Co.
·
Acorda Therapeutics, Inc.
·
Adamis Pharmaceuticals Corp.
·
Adherium Ltd.
·
AstraZeneca PLC
·
Bespak
·
Boehringer Ingelheim International GmbH
·
Chiesi Farmaceutici S.P.A.
·
GF Health
·
GlaxoSmithKline PLC
·
H&T Presspart Manufacturing Ltd.
·
Koninklijke Philips N.V.
·
Novartis AG
·
Omron Healthcare Inc.
·
ResMed Corp.
·
Pulmatrix Inc.
·
Savara, Inc.
·
Teicos Pharma Ltd.
·
Teva Pharmaceuticals Industries Ltd.
·
Vitalograph Ltd.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment